Author

Frédéric Pecorari

Centre National de la Recherche ScientifiqueORCID 0000-0002-7854-0643Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

François DavodeauiD· 2 shared Agnès Fortun· 1 shared Ana Cecília A. RoqueiD· 1 shared Arménio Jorge Moura BarbosaiD· 1 shared Barbara MouratouiD· 1 shared Blandine MoneliD· 1 shared Catherine Maurel· 1 shared Cyril PlanchaisiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

François DavodeauORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Optimized pipeline for generating highly potent neutralizing Affitins: application to SARS-CoV-2 spike protein

Thomas Maurice, Mélanie Laporte, Nicolas Barquilla, Agnès Fortun, Klára Echasserieau, Florence Guivel‐Benhassine, Arménio Jorge Moura Barbosa, Pauline Cossard, Cyril Planchais, François Anna, Pierre Charneau, Hugo Mouquet, Ana Cecília A. Roque, Olivier Schwartz, Barbara Mouratou, , Frédéric Pecorari

The paper develops a pipeline to generate potent Affitins targeting SARS-CoV-2 spike protein RBD, achieving high neutralization potency with IC50 values as low as 0.8 pM.

International Journal of Biological Macromolecules · Nov 28, 2025Peer-reviewedBiochemistry

Advantage of the F(ab)'2 fragment over IgG for RIT and PRIT

Zainab Tabaja, Maya Diab, Frédérique Nguyen, Catherine Maurel, Frédéric Pecorari, Sylvia Lambot, François Davodeau

This paper compares the therapeutic index of IgG and F(ab)2 fragments in preclinical radioimmunotherapy models, finding F(ab)2 improves therapeutic outcomes.

bioRxiv · Oct 16, 2024 · PreprintCancer Biology